Asplenia
Showing 1 - 25 of 27
Splenectomy; Status Trial (Bexsero)
Not yet recruiting
- Splenectomy; Status
- Bexsero
- (no location specified)
Aug 29, 2023
Asplenia Trial in Sacramento (Pneumovax-23)
Recruiting
- Asplenia
- Pneumovax-23
-
Sacramento, CaliforniaUniversity of California, Davis Medical Center
Jan 26, 2022
Asplenia Trial in France
Recruiting
- Asplenia
-
Angoulême, France
- +10 more
Mar 29, 2022
Anti-SARS-CoV-2 and Encapsulated Vaccination Thalassemic and
Recruiting
- SARS-CoV-2 Infection, Thalasemmie, SCD
-
Torino, TO, Italy
- +8 more
Feb 1, 2022
Molecular Genetics of Heterotaxy and Related Congenital Heart
Recruiting
- Heterotaxy Syndrome
- Congenital Heart Defects
-
Indianapolis, IndianaIndiana University School of Medicine
Feb 1, 2022
Meningococcal Vaccine Trial in Czechia, Poland, Turkey (Trumenba)
Recruiting
- Meningococcal Vaccine
- Trumenba
-
Brno 2, Czechia
- +9 more
Jun 20, 2022
A Nationwide Italian Survey on Asplenia
Completed
- Splenectomy; Status
- (no location specified)
Jun 27, 2018
Cat Bite, Hand Injuries, Arm Injury Trial (drug, other, procedure)
Not yet recruiting
- Cat Bite
- +4 more
- Amoxicillin/clavulanate
- +4 more
- (no location specified)
Apr 26, 2023
Pneumococcal Infection Trial (Pneumo 23® 0,5, Pneumo 23® 0,1, Prevenar13® 0,5)
Completed
- Pneumococcal Infection
- Pneumo 23® 0,5
- +2 more
- (no location specified)
Jul 31, 2021
Complications in Children With B- Thalassemia Major
Unknown status
- Beta-thalassemia
- Demographic, physical examination, data will becollected .
- (no location specified)
Jan 15, 2020
Prostate Cancer Trial in United States (GTx-758 125 mg, GTx-758 250 mg)
Completed
- Prostate Cancer
- GTx-758 125 mg
- GTx-758 250 mg
-
Burbank, California
- +25 more
Mar 3, 2021
Antibiotic Side Effect, Eyelid; Wound, Eyelid Diseases Trial in San Francisco (Topical Antibiotic Product, Topical
Completed
- Antibiotic Side Effect
- +8 more
- Topical Antibiotic Product
- Topical Non-Antibiotic Ointment
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 20, 2020
Increasing Infection Rates After Splenectomy
Unknown status
- Gut Microbiota
- +2 more
- splenectomy
-
Harbin, Heilongjiang, ChinaFirst affiliated hospital of Harbin medical university
Feb 22, 2019
Infections, Streptococcal, Streptococcus Pneumoniae Vaccines Trial in Poland, Russian Federation (Synflorix™)
Completed
- Infections, Streptococcal
- Streptococcus Pneumoniae Vaccines
- Synflorix™
-
Krakow, Poland
- +5 more
Jun 26, 2019
Tolerability and Immunogenicity of 4CMenB Vaccine(2 Doses)
Unknown status
- Acquired Immunodeficiency
- 4CMenB (Bexsero®) vaccine
-
Genoa, ItalyU.O.Igiene Ospedale Policlinico San Martino - IRCCS
Mar 3, 2020
Sickle Cell Disease Trial in Brussels (Inactivated influenza A (H1N1) virus vaccine, Blood sampling)
Completed
- Sickle Cell Disease
- Inactivated influenza A (H1N1) virus vaccine
- Blood sampling
-
Brussels, Belgium
- +1 more
Oct 17, 2018
Clostridium Difficile Infection Trial (MK-3415, MK-6072, MK-3415A)
Completed
- Clostridium Difficile Infection
- MK-3415
- +4 more
- (no location specified)
Aug 6, 2018
Clostridium Difficile Infection Trial (MK-6072, MK-3415A, Placebo)
Completed
- Clostridium Difficile Infection
- MK-6072
- +3 more
- (no location specified)
Aug 6, 2018
Patients With Chronic Myeloproliferative Diseases
Completed
- Myeloproliferative Disorders
- Pulmonary Hypertension
- Echocardiography, spiroergometry, cardiac catheterization
-
Graz, AustriaMedical University of Graz, Pulmonology
Sep 7, 2015
COPD (COPD) Trial in Worldwide (QVA149, QAB149, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- QVA149
- +2 more
-
Vestavia, Alabama
- +85 more
Feb 29, 2016
Feeding Intolerance in Premature Infants Using Near Infrared
Unknown status
- Feeding Intolerance
- +2 more
- (no location specified)
Aug 26, 2015
Defining Immunodeficiency in Heterotaxy Syndrome: Pilot Study
Completed
- Heterotaxy Syndrome
-
Boston, MassachusettsBoston Children's Hospital
Jun 26, 2014
Asplenia, ß-thalassemia Major Trial in Athens (PCV13)
Unknown status
- Asplenia
- β-thalassemia Major
- PCV13
-
Athens, Attiki, Greece'Aghia Sophia' Children's Hospital
May 1, 2013
Healthy Trial in Nanjing (vaccine made by Beijing Minhai Biotechnology Co., Ltd, vaccine made by Chengdu Institute of Biological
Completed
- Healthy
- vaccine made by Beijing Minhai Biotechnology Co., Ltd
- vaccine made by Chengdu Institute of Biological Products
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Diseases Control and Prevention
Mar 14, 2013